tiprankstipranks
Urogen Pharma (URGN)
NASDAQ:URGN
US Market

Urogen Pharma (URGN) Technical Analysis

Compare
460 Followers

Technical Sentiment

Overall Consensus
Strong Sell
3Bullish
5Neutral
14Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Urogen Pharma’s (URGN) Moving Averages Convergence Divergence (MACD) indicator is -0.10, suggesting Urogen Pharma is a Buy.
Urogen Pharma’s (URGN) 20-Day exponential moving average is 10.67, while Urogen Pharma’s (URGN) share price is $10.08, making it a Sell.
Urogen Pharma’s (URGN) 50-Day exponential moving average is 10.96, while Urogen Pharma’s (URGN) share price is $10.08, making it a Sell.

Urogen Pharma (URGN) Pivot Points

Feb 23, 2025, 04:20 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
10.09
10.35
10.53
10.79
10.97
11.23
11.41
Fibonacci
10.35
10.52
10.62
10.79
10.96
11.06
11.23
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Urogen Pharma (URGN) Moving Averages

Feb 23, 2025, 04:20 AM
Period
Simple
Exponential
MA5
10.59Sell
10.49Sell
MA10
10.55Sell
10.59Sell
MA20
10.77Sell
10.67Sell
MA50
10.80Sell
10.96Sell
MA100
11.54Sell
11.61Sell
MA200
13.12Sell
12.88Sell
Urogen Pharma’s (URGN) 10-Day exponential moving average is 10.59, while Urogen Pharma’s (URGN) share price is $10.08, making it a Sell.
Urogen Pharma’s (URGN) 100-Day exponential moving average is 11.61, while Urogen Pharma’s (URGN) share price is $10.08, making it a Sell.
Urogen Pharma’s (URGN) stock price is $10.08 and Urogen Pharma’s (URGN) 50-day simple moving average is 10.80, creating a Sell signal.
Urogen Pharma’s (URGN) stock price is $10.08 and Urogen Pharma’s (URGN) 100-day simple moving average is 11.54, creating a Sell signal.
Urogen Pharma’s (URGN) stock price is $10.08 and Urogen Pharma’s (URGN) 200-day simple moving average is 13.12, creating a Sell signal.

Urogen Pharma (URGN) Technical Indicators

Feb 23, 2025, 04:20 AM
Name
Value
Implied Action
RSI (14)
40.55
Neutral
STOCH (9,6)
46.97
Neutral
STOCHRSI (14)
33.67
Neutral
MACD (12,26)
-0.10
Buy
ADX (14)
12.58
Buy
Williams %R
-89.05
Buy
CCI (14)
-97.73
Neutral
ATR (14)
0.53
-
Ultimate Oscillator
40.20
Neutral
ROC
-8.45
Sell
Urogen Pharma’s (URGN) Relative Strength Index (RSI) is 40.55, creating a Neutral signal.
Urogen Pharma’s (URGN) Trend Strength Indicator (ADX) is 12.58, creating a Buy signal.
Urogen Pharma’s (URGN) Commodity Channel Index (CCI) is -97.73, creating a Neutral signal.
Urogen Pharma’s (URGN) Price Rate of Change (ROC) is -8.45, creating a Sell signal.

FAQ

Is URGN a Buy, Hold, or Sell?
Based on URGN’s technical indicators, URGN is a Strong Sell.
    What is URGN’s RSI (14)?
    URGN’s RSI (14) is 40.55, which suggests URGN is a Neutral.
      What is URGN’s MACD?
      URGN’s MACD is -0.10, which suggests URGN is a Buy.
        What is URGN’s 5-day moving average?
        URGN’s 5-day moving average is 10.59, which suggests URGN is a Sell.
          What is URGN’s 20-day moving average?
          URGN 20-day moving average is 10.77, which suggests URGN is a Sell.
            What is URGN’s 50-day moving average?
            URGN’s 50-day moving average is 10.80, which suggests URGN is a Sell.
              What is URGN’s 200-day moving average?
              URGN’s 200-day moving average is 13.12, which suggests URGN is a Sell.
                What is URGN’s Williams % R (14)?
                URGN’s Williams % R (14) is -89.05, which suggests URGN is a Buy.
                  What is URGN’s CCI (14)?
                  URGN’s CCI (14) is -97.73, which suggests URGN is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis